Universal Biosensors, Inc.

Equities

UBI

AU000000UBI2

Advanced Medical Equipment & Technology

Delayed Australian S.E. Other stock markets 02:10:53 2024-07-15 am EDT			5-day change	1st Jan Change
0.145 ^AUD	0.00%		-3.33%	-27.50%

May. 30	Transcript : Universal Biosensors, Inc. - Shareholder/Analyst Call
May. 08	Universal Biosensors Raises AU$10 Million via Entitlement Offer	MT

Viburnum Funds Engages in Discussions with Universal Biosensors

January 11, 2021 at 12:26 pm EST

On January 11, 2021, Viburnum Funds Pty Ltd announced that it has had communications with Universal Biosensors, Inc. regarding management of the Company as Craig E. Coleman has served on the Board since June 30, 2016. Viburnum Funds stated that it intends to review its investment in the Company on a continuing basis.

Latest news about Universal Biosensors, Inc.

Transcript : Universal Biosensors, Inc. - Shareholder/Analyst Call	May. 29
Universal Biosensors Raises AU$10 Million via Entitlement Offer	May. 07	MT
Universal Biosensors Narrows Q1 Loss as Revenue Rises; Shares Fall 3%	May. 02	MT
Universal Biosensors, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 01	CI
Universal Biosensors Opens AU$10 Million Rights Issue	Apr. 19	MT
Universal Biosensors to Raise AU$10 Million for Technology Development	Apr. 10	MT
H&G High Conviction Reports Flat Performance for March Quarter	Apr. 10	MT
Transcript : Universal Biosensors, Inc. - Shareholder/Analyst Call	Apr. 09
Australian Shares Rise as Central Bank Maintains Interest Rates	Mar. 19	MT
Universal Biosensors Secures US FDA Approval for Coagulation Analyzer Device; Shares Surge 78%	Mar. 18	MT
Transcript : Universal Biosensors, Inc., 2023 Earnings Call, Mar 07, 2024	Mar. 06
Universal Biosensors Narrows 2023 Loss on Absence of Impairment, Higher Revenue; Shares Down 6%	Feb. 29	MT
Universal Biosensors, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Universal Biosensors Grows H2 2023 Sales by 55%	Jan. 31	MT
Transcript : Universal Biosensors, Inc., Q3 2023 Earnings Call, Nov 02, 2023	Nov. 01
Universal Biosensors, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-29	CI
Universal Biosensors' Coagulation Analysis Device Gets Approval in Europe	23-10-04	MT
Universal Biosensors Secures Marketing Approval, First Order for Coagulation Analyzer Device in India	23-08-31	MT
Universal Biosensors Secures First Major Tender to Supply Xprecia Prime in Italy	23-08-08	MT
Transcript : Universal Biosensors, Inc., Q2 2023 Earnings Call, Aug 08, 2023	23-08-07
Australian Shares Flat Ahead of Central Bank Policy Meeting	23-07-31	MT
Universal Biosensors Narrows Net Loss 74% in H1	23-07-30	MT
Universal Biosensors, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-30	CI
Universal Biosensors, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-30	CI
Transcript : Universal Biosensors, Inc. - Shareholder/Analyst Call	23-05-21

Chart Universal Biosensors, Inc.

Duration

Period

More charts

Company Profile

Universal Biosensors, Inc. is a biosensor company. The Company is engaged in developing and commercializing a range of biosensors in oenology (wine industry), human health including oncology, coagulation, womenâs health and fertility, non-human and environmental testing using its platform technology and hand-held point-of-use devices. Its core technology consists of a disposable, multi-layer test strip, which incorporates an electrochemical sensing system using opposing electrodes that detect specific analytes in samples as small as a droplet. Its products include Sentia Wine Analyzer, Xprecia Prime Coagulation Analyzer, Hemostasis Reference Laboratory (HRL) and PETRACKR Veterinary Blood Glucose Monitoring System. HRL supports contract research organizations, central laboratories, early phase clinics, pharmaceutical/ biotechnology companies and academic researchers conducting clinical trials. HRL offers multiplex cytokine analysis on the MESO QuickPlex SQ 120MM technology platform.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-25 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
UNIVERSAL BIOSENSORS, INC.	-27.50%	29.36M
THERMO FISHER SCIENTIFIC	+2.62%	209B
DANAHER CORPORATION	+6.44%	183B
INTUITIVE SURGICAL, INC.	+29.61%	158B
BOSTON SCIENTIFIC CORPORATION	+34.96%	114B
SIEMENS HEALTHINEERS AG	+3.84%	67.29B
EDWARDS LIFESCIENCES CORPORATION	+17.38%	54.83B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-4.51%	46.88B
AGILENT TECHNOLOGIES, INC.	-5.77%	38.58B
GE HEALTHCARE TECHNOLOGIES INC.	+3.71%	36.65B

Other Advanced Medical Equipment & Technology